Freestone Capital Holdings’s ATAI Life Sciences ATAI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $43.8K | Sell |
20,000
-10,000
| -33% | -$21.9K | ﹤0.01% | 445 |
|
2025
Q1 | $40.8K | Hold |
30,000
| – | – | ﹤0.01% | 436 |
|
2024
Q4 | $39.9K | Hold |
30,000
| – | – | ﹤0.01% | 433 |
|
2024
Q3 | $34.8K | Hold |
30,000
| – | – | ﹤0.01% | 426 |
|
2024
Q2 | $39.9K | Hold |
30,000
| – | – | ﹤0.01% | 451 |
|
2024
Q1 | $59.1K | Hold |
30,000
| – | – | ﹤0.01% | 433 |
|
2023
Q4 | $42.3K | Hold |
30,000
| – | – | ﹤0.01% | 388 |
|
2023
Q3 | $38.7K | Buy |
30,000
+10,000
| +50% | +$12.9K | ﹤0.01% | 363 |
|
2023
Q2 | $34.4K | Hold |
20,000
| – | – | ﹤0.01% | 382 |
|
2023
Q1 | $36.2K | Buy |
20,000
+10,000
| +100% | +$18.1K | ﹤0.01% | 362 |
|
2022
Q4 | $26.6K | Hold |
10,000
| – | – | ﹤0.01% | 368 |
|
2022
Q3 | $33K | Hold |
10,000
| – | – | ﹤0.01% | 365 |
|
2022
Q2 | $36K | Hold |
10,000
| – | – | ﹤0.01% | 414 |
|
2022
Q1 | $51K | Buy |
+10,000
| New | +$51K | ﹤0.01% | 572 |
|